These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 17659204)
1. Role of Rac1 GTPase activation in atrial fibrillation. Adam O; Frost G; Custodis F; Sussman MA; Schäfers HJ; Böhm M; Laufs U J Am Coll Cardiol; 2007 Jul; 50(4):359-67. PubMed ID: 17659204 [TBL] [Abstract][Full Text] [Related]
2. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462 [TBL] [Abstract][Full Text] [Related]
3. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Reilly SN; Jayaram R; Nahar K; Antoniades C; Verheule S; Channon KM; Alp NJ; Schotten U; Casadei B Circulation; 2011 Sep; 124(10):1107-17. PubMed ID: 21844076 [TBL] [Abstract][Full Text] [Related]
4. Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling. Reil JC; Hohl M; Oberhofer M; Kazakov A; Kaestner L; Mueller P; Adam O; Maack C; Lipp P; Mewis C; Allessie M; Laufs U; Böhm M; Neuberger HR Cardiovasc Res; 2010 Aug; 87(3):485-93. PubMed ID: 20211865 [TBL] [Abstract][Full Text] [Related]
5. Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation. Adam O; Theobald K; Lavall D; Grube M; Kroemer HK; Ameling S; Schäfers HJ; Böhm M; Laufs U J Mol Cell Cardiol; 2011 Apr; 50(4):678-85. PubMed ID: 21215756 [TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats. Habibi J; Whaley-Connell A; Qazi MA; Hayden MR; Cooper SA; Tramontano A; Thyfault J; Stump C; Ferrario C; Muniyappa R; Sowers JR Endocrinology; 2007 May; 148(5):2181-8. PubMed ID: 17317778 [TBL] [Abstract][Full Text] [Related]
7. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy. Custodis F; Eberl M; Kilter H; Böhm M; Laufs U Cardiovasc Res; 2006 Jul; 71(2):342-51. PubMed ID: 16698001 [TBL] [Abstract][Full Text] [Related]
8. Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling. Lavall D; Schuster P; Jacobs N; Kazakov A; Böhm M; Laufs U J Biol Chem; 2017 May; 292(18):7542-7553. PubMed ID: 28320863 [TBL] [Abstract][Full Text] [Related]
9. Role of miR-21 in the pathogenesis of atrial fibrosis. Adam O; Löhfelm B; Thum T; Gupta SK; Puhl SL; Schäfers HJ; Böhm M; Laufs U Basic Res Cardiol; 2012 Sep; 107(5):278. PubMed ID: 22760500 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II activates signal transducers and activators of transcription 3 via Rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease. Xue XD; Huang JH; Wang HS Cell Biochem Biophys; 2015 Jan; 71(1):205-13. PubMed ID: 25151145 [TBL] [Abstract][Full Text] [Related]
11. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Maack C; Kartes T; Kilter H; Schäfers HJ; Nickenig G; Böhm M; Laufs U Circulation; 2003 Sep; 108(13):1567-74. PubMed ID: 12963641 [TBL] [Abstract][Full Text] [Related]
12. Rac1-mediated effects of HMG-CoA reductase inhibitors (statins) in cardiovascular disease. Adam O; Laufs U Antioxid Redox Signal; 2014 Mar; 20(8):1238-50. PubMed ID: 23919665 [TBL] [Abstract][Full Text] [Related]
13. Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β. Yeh YH; Kuo CT; Chang GJ; Qi XY; Nattel S; Chen WJ Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):790-8. PubMed ID: 23884197 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker. Fujita M; Cheng XW; Inden Y; Shimano M; Yoshida N; Inoue A; Yamamoto T; Takeshita K; Kyo S; Taguchi N; Shi GP; Kuzuya M; Okumura K; Murohara T J Am Heart Assoc; 2013 Dec; 2(6):e000503. PubMed ID: 24342995 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blockers and statins could alleviate atrial fibrosis via regulating platelet-derived growth factor/Rac1/nuclear factor-kappa B Axis. Yang D; Yuan J; Liu G; Ling Z; Zeng H; Chen Y; Zhang Y; She Q; Zhou X Int J Med Sci; 2013; 10(7):812-24. PubMed ID: 23794945 [TBL] [Abstract][Full Text] [Related]
16. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials. Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ; ; Circulation; 2015 Apr; 131(17):1486-94; discussion 1494. PubMed ID: 25810334 [TBL] [Abstract][Full Text] [Related]
17. Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice. Mighiu AS; Recalde A; Ziberna K; Carnicer R; Tomek J; Bub G; Brewer AC; Verheule S; Shah AM; Simon JN; Casadei B Cardiovasc Res; 2021 Sep; 117(11):2354-2364. PubMed ID: 33483749 [TBL] [Abstract][Full Text] [Related]